The Uromigos Episode 176: 3 Posters Discuss HER2-Targeting Antibody Drug Conjugates

By The Uromigos - Last Updated: June 5, 2022

Matt Galsky joins the Uromigos to discuss 3 research posters presented at ASCO 2022 that cover the effects of HER2-targeting ADCs for urothelial cancer.

Post Tags:Uromigos-ASCO
Did you like this article?